BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND FOXA1, TCF3A, 3169, ENSG00000129514, P55317, HNF3A, MGC33105
28 results:

  • 1. Exploration of the damage and mechanisms of BPS exposure on the uterus and ovary of adult female mice.
    Yue H; Tian Y; Wu X; Yang X; Xu P; Zhu H; Sang N
    Sci Total Environ; 2023 Apr; 868():161660. PubMed ID: 36690098
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Systematic Pan-cancer Analysis and Experimental Verification Identify foxa1 as an Immunological and Prognostic Biomarker in Epithelial ovarian cancer.
    Wang K; Guan C; Yu J; Chen X; Shang X; Mei S; Feng X; Zheng L
    Dis Markers; 2022; 2022():9328972. PubMed ID: 36393971
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Immunohistochemical evaluation of forkhead box A1 and EphA5 markers in serous ovarian carcinomas, and their impact on the clinical outcome of patients.
    Abouhashem N; Harb O; Elwan A; Zaitoun M; Saraya Y
    Pol J Pathol; 2022; 73(2):120-133. PubMed ID: 36345952
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Contemporary primary treatment of women with stage II-IV low-grade serous ovarian/peritoneal cancer (LGSOC): Determinants of relapse and disease-free survival.
    Gershenson DM; Cobb LP; Westin SN; Zhang Y; Jazaeri A; Malpica A; Sun CC
    Gynecol Oncol; 2022 Nov; 167(2):139-145. PubMed ID: 36137845
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Serum Autoantibodies against LRDD, STC1, and foxa1 as Biomarkers in the Detection of ovarian cancer.
    Duan Y; Cui C; Qiu C; Sun G; Wang X; Wang P; Ye H; Dai L; Shi J
    Dis Markers; 2022; 2022():6657820. PubMed ID: 35273656
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. foxa1 can be modulated by HDAC3 in the progression of epithelial ovarian carcinoma.
    Lou T; Liu C; Qu H; Zhang Z; Wang S; Zhuang H
    J Transl Med; 2022 Jan; 20(1):19. PubMed ID: 34991620
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Differential gene expression identifies a transcriptional regulatory network involving ER-alpha and PITX1 in invasive epithelial ovarian cancer.
    Li Y; Jaiswal SK; Kaur R; Alsaadi D; Liang X; Drews F; DeLoia JA; Krivak T; Petrykowska HM; Gotea V; Welch L; Elnitski L
    BMC Cancer; 2021 Jul; 21(1):768. PubMed ID: 34215221
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. High foxa1 immunohistochemical expression level associates with mucinous histology, favorable clinico-pathological prognostic parameters and survival advantage in epithelial ovarian cancer.
    Sheta H; Abd El Hafez A; Saif M; Elsergany AR; Al Emam D; Abdelrazik MM
    Pathologica; 2021 Apr; 113(2):102-114. PubMed ID: 34042091
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. foxa1 is associated with high tumor grade, myometrial invasion and lymph node invasion in endometrial endometrioid carcinoma.
    Tosun Yıldırım H; Nergiz D; Sadullahoğlu C; Süren D; Yıldırım Ş; Üreyen I; Sezer C
    Ginekol Pol; 2021; 92(8):544-549. PubMed ID: 33844251
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. foxa1 Expression by Immunohistochemistry in Carcinosarcomas of the Endometrium and Ovary/Fallopian Tube.
    Karpathiou G; Chauleur C; Dal Col P; Peoc'h M
    Int J Gynecol Pathol; 2021 Nov; 40(6):611-616. PubMed ID: 33770058
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. LncRNA SNHG17 promotes proliferation and invasion of ovarian cancer cells through up-regulating foxa1.
    Zheng ZJ; Liu Y; Wang HJ; Pang WW; Wang Y
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9282-9289. PubMed ID: 33015769
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Deletion of Cdkn1b in ACI rats leads to increased proliferation and pregnancy-associated changes in the mammary gland due to perturbed systemic endocrine environment.
    Ding L; Shunkwiler LB; Harper NW; Zhao Y; Hinohara K; Huh SJ; Ekram MB; Guz J; Kern MJ; Awgulewitsch A; Shull JD; Smits BMG; Polyak K
    PLoS Genet; 2019 Mar; 15(3):e1008002. PubMed ID: 30893315
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Effects of forkhead Box protein A1 on cell proliferation regulating and EMT of cervical carcinoma.
    Gu F; Li ZH; Wang CQ; Yuan QF; Yan ZM
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7189-7196. PubMed ID: 30468461
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The transcription factor foxa1 induces epithelial ovarian cancer tumorigenesis and progression.
    Wang LL; Xiu YL; Chen X; Sun KX; Chen S; Wu DD; Liu BL; Zhao Y
    Tumour Biol; 2017 May; 39(5):1010428317706210. PubMed ID: 28488543
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. foxa1 is expressed in ovarian mucinous neoplasms.
    Karpathiou G; Venet M; Mobarki M; Forest F; Chauleur C; Peoc'h M
    Pathology; 2017 Apr; 49(3):271-276. PubMed ID: 28238418
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. MicroRNA-93 Promotes Epithelial-Mesenchymal Transition of Endometrial Carcinoma Cells.
    Chen S; Chen X; Sun KX; Xiu YL; Liu BL; Feng MX; Sang XB; Zhao Y
    PLoS One; 2016; 11(11):e0165776. PubMed ID: 27829043
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. GATA-3 and foxa1 expression is useful to differentiate breast carcinoma from other carcinomas.
    Davis DG; Siddiqui MT; Oprea-Ilies G; Stevens K; Osunkoya AO; Cohen C; Li XB
    Hum Pathol; 2016 Jan; 47(1):26-31. PubMed ID: 26527523
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.
    Orr N; Dudbridge F; Dryden N; Maguire S; Novo D; Perrakis E; Johnson N; Ghoussaini M; Hopper JL; Southey MC; Apicella C; Stone J; Schmidt MK; Broeks A; Van't Veer LJ; Hogervorst FB; Fasching PA; Haeberle L; Ekici AB; Beckmann MW; Gibson L; Aitken Z; Warren H; Sawyer E; Tomlinson I; Kerin MJ; Miller N; Burwinkel B; Marme F; Schneeweiss A; Sohn C; Guénel P; Truong T; Cordina-Duverger E; Sanchez M; Bojesen SE; Nordestgaard BG; Nielsen SF; Flyger H; Benitez J; Zamora MP; Arias Perez JI; Menéndez P; Anton-Culver H; Neuhausen SL; Brenner H; Dieffenbach AK; Arndt V; Stegmaier C; Hamann U; Brauch H; Justenhoven C; Brüning T; Ko YD; Nevanlinna H; Aittomäki K; Blomqvist C; Khan S; Bogdanova N; Dörk T; Lindblom A; Margolin S; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Chenevix-Trench G; Beesley J; Lambrechts D; Moisse M; Floris G; Beuselinck B; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Radice P; Peterlongo P; Peissel B; Pensotti V; Couch FJ; Olson JE; Slettedahl S; Vachon C; Giles GG; Milne RL; McLean C; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Simard J; Goldberg MS; Labrèche F; Dumont M; Kristensen V; Alnæs GG; Nord S; Borresen-Dale AL; Zheng W; Deming-Halverson S; Shrubsole M; Long J; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Andrulis IL; Knight JA; Glendon G; Tchatchou S; Devilee P; Tollenaar RA; Seynaeve CM; Van Asperen CJ; Garcia-Closas M; Figueroa J; Chanock SJ; Lissowska J; Czene K; Darabi H; Eriksson M; Klevebring D; Hooning MJ; Hollestelle A; van Deurzen CH; Kriege M; Hall P; Li J; Liu J; Humphreys K; Cox A; Cross SS; Reed MW; Pharoah PD; Dunning AM; Shah M; Perkins BJ; Jakubowska A; Lubinski J; Jaworska-Bieniek K; Durda K; Ashworth A; Swerdlow A; Jones M; Schoemaker MJ; Meindl A; Schmutzler RK; Olswold C; Slager S; Toland AE; Yannoukakos D; Muir K; Lophatananon A; Stewart-Brown S; Siriwanarangsan P; Matsuo K; Ito H; Iwata H; Ishiguro J; Wu AH; Tseng CC; Van Den Berg D; Stram DO; Teo SH; Yip CH; Kang P; Ikram MK; Shu XO; Lu W; Gao YT; Cai H; Kang D; Choi JY; Park SK; Noh DY; Hartman M; Miao H; Lim WY; Lee SC; Sangrajrang S; Gaborieau V; Brennan P; Mckay J; Wu PE; Hou MF; Yu JC; Shen CY; Blot W; Cai Q; Signorello LB; Luccarini C; Bayes C; Ahmed S; Maranian M; Healey CS; González-Neira A; Pita G; Alonso MR; Álvarez N; Herrero D; Tessier DC; Vincent D; Bacot F; Hunter DJ; Lindstrom S; Dennis J; Michailidou K; Bolla MK; Easton DF; dos Santos Silva I; Fletcher O; Peto J; ; ;
    Hum Mol Genet; 2015 May; 24(10):2966-84. PubMed ID: 25652398
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The expression and correlation between the transcription factor FOXP1 and estrogen receptors in epithelial ovarian cancer.
    Hu Z; Zhu L; Tan M; Cai M; Deng L; Yu G; Liu D; Liu J; Lin B
    Biochimie; 2015 Feb; 109():42-8. PubMed ID: 25500588
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.
    Ghoussaini M; Edwards SL; Michailidou K; Nord S; Cowper-Sal Lari R; Desai K; Kar S; Hillman KM; Kaufmann S; Glubb DM; Beesley J; Dennis J; Bolla MK; Wang Q; Dicks E; Guo Q; Schmidt MK; Shah M; Luben R; Brown J; Czene K; Darabi H; Eriksson M; Klevebring D; Bojesen SE; Nordestgaard BG; Nielsen SF; Flyger H; Lambrechts D; Thienpont B; Neven P; Wildiers H; Broeks A; Van't Veer LJ; Th Rutgers EJ; Couch FJ; Olson JE; Hallberg E; Vachon C; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Peto J; Dos-Santos-Silva I; Gibson L; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Hall P; Li J; Liu J; Humphreys K; Kang D; Choi JY; Park SK; Noh DY; Matsuo K; Ito H; Iwata H; Yatabe Y; Guénel P; Truong T; Menegaux F; Sanchez M; Burwinkel B; Marme F; Schneeweiss A; Sohn C; Wu AH; Tseng CC; Van Den Berg D; Stram DO; Benitez J; Zamora MP; Perez JI; Menéndez P; Shu XO; Lu W; Gao YT; Cai Q; Cox A; Cross SS; Reed MW; Andrulis IL; Knight JA; Glendon G; Tchatchou S; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Lindblom A; Margolin S; Teo SH; Yip CH; Lee DS; Wong TY; Hooning MJ; Martens JW; Collée JM; van Deurzen CH; Hopper JL; Southey MC; Tsimiklis H; Kapuscinski MK; Shen CY; Wu PE; Yu JC; Chen ST; Alnæs GG; Borresen-Dale AL; Giles GG; Milne RL; McLean C; Muir K; Lophatananon A; Stewart-Brown S; Siriwanarangsan P; Hartman M; Miao H; Buhari SA; Teo YY; Fasching PA; Haeberle L; Ekici AB; Beckmann MW; Brenner H; Dieffenbach AK; Arndt V; Stegmaier C; Swerdlow A; Ashworth A; Orr N; Schoemaker MJ; García-Closas M; Figueroa J; Chanock SJ; Lissowska J; Simard J; Goldberg MS; Labrèche F; Dumont M; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Brauch H; Brüning T; Koto YD; Radice P; Peterlongo P; Bonanni B; Volorio S; Dörk T; Bogdanova NV; Helbig S; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Devilee P; Tollenaar RA; Seynaeve C; Van Asperen CJ; Jakubowska A; Lubinski J; Jaworska-Bieniek K; Durda K; Slager S; Toland AE; Ambrosone CB; Yannoukakos D; Sangrajrang S; Gaborieau V; Brennan P; McKay J; Hamann U; Torres D; Zheng W; Long J; Anton-Culver H; Neuhausen SL; Luccarini C; Baynes C; Ahmed S; Maranian M; Healey CS; González-Neira A; Pita G; Alonso MR; Alvarez N; Herrero D; Tessier DC; Vincent D; Bacot F; de Santiago I; Carroll J; Caldas C; Brown MA; Lupien M; Kristensen VN; Pharoah PD; Chenevix-Trench G; French JD; Easton DF; Dunning AM; ;
    Nat Commun; 2014 Sep; 4():4999. PubMed ID: 25248036
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.